-
1
-
-
80054021222
-
Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors
-
Cai C, Chen S, Ng P, Bubley GJ, Nelson PS, Mostaghel EA, Marck B, Matsumoto AM, Simon NI, Wang H, Balk SP. Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors. Cancer Res. 2011; 71:6503-6513.
-
(2011)
Cancer Res
, vol.71
, pp. 6503-6513
-
-
Cai, C.1
Chen, S.2
Ng, P.3
Bubley, G.J.4
Nelson, P.S.5
Mostaghel, E.A.6
Marck, B.7
Matsumoto, A.M.8
Simon, N.I.9
Wang, H.10
Balk, S.P.11
-
2
-
-
79961202865
-
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
-
Prensner JR, Iyer MK, Balbin OA, Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso CS, Kominsky HD, Cao X, Jing X, Wang X, Siddiqui J, Wei JT, Robinson D, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nature Biotechnology. 2011; 29:742-749.
-
(2011)
Nature Biotechnology
, vol.29
, pp. 742-749
-
-
Prensner, J.R.1
Iyer, M.K.2
Balbin, O.A.3
Dhanasekaran, S.M.4
Cao, Q.5
Brenner, J.C.6
Laxman, B.7
Asangani, I.A.8
Grasso, C.S.9
Kominsky, H.D.10
Cao, X.11
Jing, X.12
Wang, X.13
Siddiqui, J.14
Wei, J.T.15
Robinson, D.16
-
3
-
-
84929956213
-
Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma
-
Ma KX, Wang HJ, Li XR, Li T, Su G, Yang P, Wu JW. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma. Tumor Biol. 2015; 36:3355-3359.
-
(2015)
Tumor Biol
, vol.36
, pp. 3355-3359
-
-
Ma, K.X.1
Wang, H.J.2
Li, X.R.3
Li, T.4
Su, G.5
Yang, P.6
Wu, J.W.7
-
4
-
-
84929390668
-
Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer
-
Pang EJ, Yang R, Fu XB, Liu YF. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumor Biol. 2015; 36:2403-2407.
-
(2015)
Tumor Biol
, vol.36
, pp. 2403-2407
-
-
Pang, E.J.1
Yang, R.2
Fu, X.B.3
Liu, Y.F.4
-
5
-
-
84921032534
-
Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer
-
Shen L, Chen L, Wang Y, Jiang X, Xia H, Zhuang Z. Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer. J Neurooncol. 2015; 121:101-108.
-
(2015)
J Neurooncol
, vol.121
, pp. 101-108
-
-
Shen, L.1
Chen, L.2
Wang, Y.3
Jiang, X.4
Xia, H.5
Zhuang, Z.6
-
6
-
-
84881092106
-
Long noncoding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer
-
Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J, Wei M, Xu C, Wu C, Zhang Z, Gao X, Liu Z, Hou J, Huang J. Long noncoding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer. 2013; 49:2949-2959.
-
(2013)
Eur J Cancer
, vol.49
, pp. 2949-2959
-
-
Ren, S.1
Wang, F.2
Shen, J.3
Sun, Y.4
Xu, W.5
Lu, J.6
Wei, M.7
Xu, C.8
Wu, C.9
Zhang, Z.10
Gao, X.11
Liu, Z.12
Hou, J.13
Huang, J.14
-
7
-
-
84888640327
-
Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer
-
Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F, Wei M, Shen J, Hou J, Gao X, Xu C, Huang J, Zhao Y. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013; 190:2278-2287.
-
(2013)
J Urol
, vol.190
, pp. 2278-2287
-
-
Ren, S.1
Liu, Y.2
Xu, W.3
Sun, Y.4
Lu, J.5
Wang, F.6
Wei, M.7
Shen, J.8
Hou, J.9
Gao, X.10
Xu, C.11
Huang, J.12
Zhao, Y.13
-
8
-
-
84917730452
-
Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer
-
Wang F, Ren S, Chen R, Lu J, Shi X, Zhu Y, Zhang W, Jing T, Zhang C, Shen J, Xu C, Wang H, Wang Y, Liu B, Li Y, Fang Z, et al. Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer. Oncotarget. 2014; 5:11091-11102.
-
(2014)
Oncotarget
, vol.5
, pp. 11091-11102
-
-
Wang, F.1
Ren, S.2
Chen, R.3
Lu, J.4
Shi, X.5
Zhu, Y.6
Zhang, W.7
Jing, T.8
Zhang, C.9
Shen, J.10
Xu, C.11
Wang, H.12
Wang, Y.13
Liu, B.14
Li, Y.15
Fang, Z.16
-
9
-
-
84921718196
-
Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer
-
Sowalsky AG, Xia Z, Wang L, Zhao H, Chen S, Bubley GJ, Balk SP, Li W. Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer. Mol Cancer Res. 2015; 13:98-106.
-
(2015)
Mol Cancer Res
, vol.13
, pp. 98-106
-
-
Sowalsky, A.G.1
Xia, Z.2
Wang, L.3
Zhao, H.4
Chen, S.5
Bubley, G.J.6
Balk, S.P.7
Li, W.8
-
10
-
-
57649124289
-
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
-
Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, Mehra R, Laxman B, Cao X, Yu J, Kleer CG, Varambally S, Chinnaiyan AM. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene. 2008; 27:7274-7284.
-
(2008)
Oncogene
, vol.27
, pp. 7274-7284
-
-
Cao, Q.1
Yu, J.2
Dhanasekaran, S.M.3
Kim, J.H.4
Mani, R.S.5
Tomlins, S.A.6
Mehra, R.7
Laxman, B.8
Cao, X.9
Yu, J.10
Kleer, C.G.11
Varambally, S.12
Chinnaiyan, A.M.13
-
11
-
-
55949136562
-
Roles of the EZH2 histone methyltransferase in cancer epigenetics
-
Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutation research. 2008; 647:21-29.
-
(2008)
Mutation research
, vol.647
, pp. 21-29
-
-
Simon, J.A.1
Lange, C.A.2
-
12
-
-
33644822360
-
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
-
Bachmann IM, Halvorsen OJ, Collett K, Stefansson IM, Straume O, Haukaas SA, Salvesen HB, Otte AP, Akslen LA. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol. 2006; 24:268-273.
-
(2006)
J Clin Oncol
, vol.24
, pp. 268-273
-
-
Bachmann, I.M.1
Halvorsen, O.J.2
Collett, K.3
Stefansson, I.M.4
Straume, O.5
Haukaas, S.A.6
Salvesen, H.B.7
Otte, A.P.8
Akslen, L.A.9
-
13
-
-
34047229950
-
EZH2 promotes proliferation and invasiveness of prostate cancer cells
-
Bryant RJ, Cross NA, Eaton CL, Hamdy FC, Cunliffe VT. EZH2 promotes proliferation and invasiveness of prostate cancer cells. Prostate. 2007; 67:547-556.
-
(2007)
Prostate
, vol.67
, pp. 547-556
-
-
Bryant, R.J.1
Cross, N.A.2
Eaton, C.L.3
Hamdy, F.C.4
Cunliffe, V.T.5
-
14
-
-
33646596977
-
The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer
-
Saramaki OR, Tammela TL, Martikainen PM, Vessella RL, Visakorpi T. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer. Genes Chromosomes Cancer. 2006; 45:639-645.
-
(2006)
Genes Chromosomes Cancer
, vol.45
, pp. 639-645
-
-
Saramaki, O.R.1
Tammela, T.L.2
Martikainen, P.M.3
Vessella, R.L.4
Visakorpi, T.5
-
15
-
-
77951118936
-
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
-
Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010; 464:1071-1076.
-
(2010)
Nature
, vol.464
, pp. 1071-1076
-
-
Gupta, R.A.1
Shah, N.2
Wang, K.C.3
Kim, J.4
Horlings, H.M.5
Wong, D.J.6
Tsai, M.C.7
Hung, T.8
Argani, P.9
Rinn, J.L.10
Wang, Y.11
Brzoska, P.12
Kong, B.13
Li, R.14
West, R.B.15
van de Vijver, M.J.16
-
16
-
-
78649807567
-
Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA
-
Kaneko S, Li G, Son J, Xu CF, Margueron R, Neubert TA, Reinberg D. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev. 2010; 24:2615-2620.
-
(2010)
Genes Dev
, vol.24
, pp. 2615-2620
-
-
Kaneko, S.1
Li, G.2
Son, J.3
Xu, C.F.4
Margueron, R.5
Neubert, T.A.6
Reinberg, D.7
-
17
-
-
84878610451
-
BRCA1 is a negative modulator of the PRC2 complex
-
Wang L, Zeng X, Chen S, Ding L, Zhong J, Zhao JC, Sarver A, Koller A, Zhi J, Ma Y, Yu J, Chen J, Huang H. BRCA1 is a negative modulator of the PRC2 complex. Embo J. 2013; 32:1584-1597.
-
(2013)
Embo J
, vol.32
, pp. 1584-1597
-
-
Wang, L.1
Zeng, X.2
Chen, S.3
Ding, L.4
Zhong, J.5
Zhao, J.C.6
Sarver, A.7
Koller, A.8
Zhi, J.9
Ma, Y.10
Yu, J.11
Chen, J.12
Huang, H.13
-
18
-
-
84896505509
-
TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12
-
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y. TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res. 2014; 20:1531-1541.
-
(2014)
Clin Cancer Res
, vol.20
, pp. 1531-1541
-
-
Fan, Y.1
Shen, B.2
Tan, M.3
Mu, X.4
Qin, Y.5
Zhang, F.6
Liu, Y.7
-
19
-
-
84938988506
-
Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205
-
Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai ZL, Ishii N, Dahiya R. Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res. 2015.
-
(2015)
Cancer Res
-
-
Hirata, H.1
Hinoda, Y.2
Shahryari, V.3
Deng, G.4
Nakajima, K.5
Tabatabai, Z.L.6
Ishii, N.7
Dahiya, R.8
-
20
-
-
84887460647
-
PRC2 binds active promoters and contacts nascent RNAs in embryonic stem cells
-
Kaneko S, Son J, Shen SS, Reinberg D, Bonasio R. PRC2 binds active promoters and contacts nascent RNAs in embryonic stem cells. Nat Struct Mol Biol. 2013; 20:1258-1264.
-
(2013)
Nat Struct Mol Biol
, vol.20
, pp. 1258-1264
-
-
Kaneko, S.1
Son, J.2
Shen, S.S.3
Reinberg, D.4
Bonasio, R.5
-
21
-
-
0034749615
-
Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state
-
Murillo H, Huang H, Schmidt LJ, Smith DI, Tindall DJ. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology. 2001; 142:4795-4805.
-
(2001)
Endocrinology
, vol.142
, pp. 4795-4805
-
-
Murillo, H.1
Huang, H.2
Schmidt, L.J.3
Smith, D.I.4
Tindall, D.J.5
-
22
-
-
78149285100
-
Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2
-
Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, Zhou X, Bagchi A, Simon JA, Huang H. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat Cell Biol. 2010; 12:1108-1114.
-
(2010)
Nat Cell Biol
, vol.12
, pp. 1108-1114
-
-
Chen, S.1
Bohrer, L.R.2
Rai, A.N.3
Pan, Y.4
Gan, L.5
Zhou, X.6
Bagchi, A.7
Simon, J.A.8
Huang, H.9
-
23
-
-
33748951908
-
Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer
-
Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle. 2006; 5:1886-1901.
-
(2006)
Cell Cycle
, vol.5
, pp. 1886-1901
-
-
Berezovska, O.P.1
Glinskii, A.B.2
Yang, Z.3
Li, X.M.4
Hoffman, R.M.5
Glinsky, G.V.6
-
24
-
-
77249104533
-
Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis
-
Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, Chen H, Sun X, Boothman DA, Min W, Hsieh JT. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci U S A. 2010; 107:2485-2490.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 2485-2490
-
-
Xie, D.1
Gore, C.2
Liu, J.3
Pong, R.C.4
Mason, R.5
Hao, G.6
Long, M.7
Kabbani, W.8
Yu, L.9
Zhang, H.10
Chen, H.11
Sun, X.12
Boothman, D.A.13
Min, W.14
Hsieh, J.T.15
-
25
-
-
18644382388
-
The polycomb group protein EZH2 is involved in progression of prostate cancer
-
Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002; 419:624-629.
-
(2002)
Nature
, vol.419
, pp. 624-629
-
-
Varambally, S.1
Dhanasekaran, S.M.2
Zhou, M.3
Barrette, T.R.4
Kumar-Sinha, C.5
Sanda, M.G.6
Ghosh, D.7
Pienta, K.J.8
Sewalt, R.G.9
Otte, A.P.10
Rubin, M.A.11
Chinnaiyan, A.M.12
-
26
-
-
84863723010
-
The mutational landscape of lethal castration-resistant prostate cancer
-
Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, Anstett M, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012; 487:239-243.
-
(2012)
Nature
, vol.487
, pp. 239-243
-
-
Grasso, C.S.1
Wu, Y.M.2
Robinson, D.R.3
Cao, X.4
Dhanasekaran, S.M.5
Khan, A.P.6
Quist, M.J.7
Jing, X.8
Lonigro, R.J.9
Brenner, J.C.10
Asangani, I.A.11
Ateeq, B.12
Chun, S.Y.13
Siddiqui, J.14
Sam, L.15
Anstett, M.16
-
27
-
-
84871052080
-
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent
-
Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, Wu X, Stack EC, Loda M, Liu T, Xu H, Cato L, Thornton JE, Gregory RI, Morrissey C, Vessella RL, et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science. 2012; 338:1465-1469.
-
(2012)
Science
, vol.338
, pp. 1465-1469
-
-
Xu, K.1
Wu, Z.J.2
Groner, A.C.3
He, H.H.4
Cai, C.5
Lis, R.T.6
Wu, X.7
Stack, E.C.8
Loda, M.9
Liu, T.10
Xu, H.11
Cato, L.12
Thornton, J.E.13
Gregory, R.I.14
Morrissey, C.15
Vessella, R.L.16
-
28
-
-
84868519473
-
A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails
-
Wilusz JE, Jnbaptiste CK, Lu LY, Kuhn CD, Joshua-Tor L, Sharp PA. A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails. Genes Dev. 2012; 26:2392-2407.
-
(2012)
Genes Dev
, vol.26
, pp. 2392-2407
-
-
Wilusz, J.E.1
Jnbaptiste, C.K.2
Lu, L.Y.3
Kuhn, C.D.4
Joshua-Tor, L.5
Sharp, P.A.6
-
29
-
-
79955996135
-
MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis
-
Xu C, Yang M, Tian J, Wang X, Li Z. MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol. 2011; 39:169-175.
-
(2011)
Int J Oncol
, vol.39
, pp. 169-175
-
-
Xu, C.1
Yang, M.2
Tian, J.3
Wang, X.4
Li, Z.5
-
30
-
-
48549089747
-
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
-
Dehm SM, Schmidt LJ, Heemers HV, Vessella RL, Tindall DJ. Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Res. 2008; 68:5469-5477.
-
(2008)
Cancer Res
, vol.68
, pp. 5469-5477
-
-
Dehm, S.M.1
Schmidt, L.J.2
Heemers, H.V.3
Vessella, R.L.4
Tindall, D.J.5
-
31
-
-
65449136284
-
TopHat: discovering splice junctions with RNA-Seq
-
Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009; 25:1105-1111.
-
(2009)
Bioinformatics
, vol.25
, pp. 1105-1111
-
-
Trapnell, C.1
Pachter, L.2
Salzberg, S.L.3
-
32
-
-
84865074382
-
RSeQC: quality control of RNAseq experiments
-
Wang L, Wang S, Li W. RSeQC: quality control of RNAseq experiments. Bioinformatics. 2012; 28:2184-2185.
-
(2012)
Bioinformatics
, vol.28
, pp. 2184-2185
-
-
Wang, L.1
Wang, S.2
Li, W.3
-
33
-
-
84897421206
-
CBP Loss Cooperates with PTEN Haploinsufficiency to Drive Prostate Cancer: Implications for Epigenetic Therapy
-
Ding L, Chen S, Liu P, Pan Y, Zhong J, Regan KM, Wang L, Yu C, Rizzardi A, Cheng L, Zhang J, Schmechel SC, Cheville JC, Van Deursen J, Tindall DJ, Huang H. CBP Loss Cooperates with PTEN Haploinsufficiency to Drive Prostate Cancer: Implications for Epigenetic Therapy. Cancer Res. 2014; 74:2050-2061.
-
(2014)
Cancer Res
, vol.74
, pp. 2050-2061
-
-
Ding, L.1
Chen, S.2
Liu, P.3
Pan, Y.4
Zhong, J.5
Regan, K.M.6
Wang, L.7
Yu, C.8
Rizzardi, A.9
Cheng, L.10
Zhang, J.11
Schmechel, S.C.12
Cheville, J.C.13
Van Deursen, J.14
Tindall, D.J.15
Huang, H.16
|